TipRanks
Neuphoria Therapeutics (DE:B1N0)
FRANKFURT:B1N0
Germany Market
B1N0
Neuphoria Therapeutics
RESEARCH TOOLSreports

Neuphoria Therapeutics (B1N0) Ratios

2 Followers

Neuphoria Therapeutics Ratios

DE:B1N0's free cash flow for Q4 2026 was AU$0.86. For the 2026 fiscal year, DE:B1N0's free cash flow was decreased by AU$ and operating cash flow was AU$-0.14. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 27.85 27.85 3.56 3.45 4.87
Quick Ratio
 27.85 27.85 3.56 3.45 4.87
Cash Ratio
 26.26 26.26 3.37 3.29 4.42
Solvency Ratio
 -4.31 >-0.01 0.04 -2.19 -4.42
Operating Cash Flow Ratio
 -16.33K -16.33 12.04 -3.83 -5.40
Short-Term Operating Cash Flow Coverage
 -359.69K -359.68K 1.55K -443.27 -100.57
Net Current Asset Value
AU$ 16.96M$ 16.96B$ 8.29M$ 3.04MAU$ 4.13M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.02 0.02
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.02 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.17 1.17 1.50 1.58 1.32
Debt Service Coverage Ratio
 -361.38 -262.29 6.96 -670.31 -214.25
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 0.14 <0.01 <0.01
Net Debt to EBITDA
 1.58 2.17K 175.27 0.55 0.36
Profitability Margins
Gross Profit Margin
43.54%43.54%95.76%0.00%0.00%
EBIT Margin
-1141.17%-835.53%-7.21%0.00%0.00%
EBITDA Margin
-1070.43%-779.07%-0.78%0.00%0.00%
Operating Profit Margin
-1187.73%-835.53%-7.21%0.00%0.00%
Pretax Profit Margin
-1591.77%-1157.51%-5.35%0.00%0.00%
Net Profit Margin
-1578.40%-1145.66%-2.36%0.00%0.00%
Continuous Operations Profit Margin
-1578.40%-1145.66%-2.36%0.00%0.00%
Net Income Per EBT
99.16%98.98%44.11%99.44%97.44%
EBT Per EBIT
134.02%138.54%74.22%87.07%99.82%
Return on Assets (ROA)
-64.55%-0.05%-0.85%-83.88%-111.62%
Return on Equity (ROE)
-77.03%-0.05%-1.28%-132.61%-147.75%
Return on Capital Employed (ROCE)
-49.89%-0.04%-3.05%-112.45%-126.66%
Return on Invested Capital (ROIC)
-49.41%-0.03%-1.34%-111.10%-122.74%
Return on Tangible Assets
-87.96%-0.06%-1.61%-171.92%-227.24%
Earnings Yield
-93.83%-70.02%-3.21%-1.87%-0.45%
Efficiency Ratios
Receivables Turnover
 1.44 1.44 1.31K 0.00 0.00
Payables Turnover
 1.72 1.72 0.38 0.44 0.70
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 97.74 0.00 0.00
Asset Turnover
 0.04 <0.01 0.36 0.00 0.00
Working Capital Turnover Ratio
 0.06 <0.01 1.21 0.00 0.00
Cash Conversion Cycle
 40.57 40.57 -965.48 -825.20 -520.83
Days of Sales Outstanding
 252.86 252.86 0.28 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 212.29 212.29 965.76 825.20 520.83
Operating Cycle
 252.86 252.86 0.28 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.28K -2.81K 47.59 -0.10 -0.08
Free Cash Flow Per Share
 -2.28K -2.81K 47.59 -0.10 -0.08
CapEx Per Share
 0.00 <0.01 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -3.09B 0.00 0.00 -39.43M
Capital Expenditure Coverage Ratio
 0.00 -3.09B 0.00 0.00 -39.43M
Operating Cash Flow Coverage Ratio
 -359.69K -359.68K 340.99 -53.83 -38.23
Operating Cash Flow to Sales Ratio
 -10.52K -10.52K 4.93 0.00 0.00
Free Cash Flow Yield
-62624.08%-64303.69%670.23%-1.18%-0.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.50 -1.43 -30.87 -53.48 -224.01
Price-to-Sales (P/S) Ratio
 16.80 16.36 0.74 0.00 0.00
Price-to-Book (P/B) Ratio
 0.80 <0.01 0.40 70.92 330.97
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 >-0.01 0.15 -84.49 -492.49
Price-to-Operating Cash Flow Ratio
 >-0.01 >-0.01 0.15 -84.49 -492.49
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 >-0.01 -0.24 1.30 -7.28
Price-to-Fair Value
 0.80 <0.01 0.40 70.92 330.97
Enterprise Value Multiple
 <0.01 2.17K 80.75 -54.99 -224.71
Enterprise Value
 -104.58K -19.85B -9.84M 1.23B 4.84B
EV to EBITDA
 <0.01 2.17K 80.75 -54.99 -224.71
EV to Sales
 -0.09 -16.90K -0.63 0.00 0.00
EV to Free Cash Flow
 <0.01 1.61 -0.13 -83.65 -491.70
EV to Operating Cash Flow
 <0.01 1.61 -0.13 -83.65 -491.70
Tangible Book Value Per Share
 3.13 3.86K 5.20 0.02 0.04
Shareholders’ Equity Per Share
 4.55 5.60K 17.79 0.12 0.12
Tax and Other Ratios
Effective Tax Rate
 <0.01 0.01 0.56 <0.01 0.03
Revenue Per Share
 0.22 0.27 9.64 0.00 0.00
Net Income Per Share
 -3.42 -3.06 -0.23 -0.15 -0.18
Tax Burden
 0.99 0.99 0.44 0.99 0.97
Interest Burden
 1.39 1.39 0.74 1.00 1.00
Research & Development to Revenue
 5.13 3.02K 0.58 0.00 0.00
SG&A to Revenue
 8.21 6.34K 0.50 0.00 0.00
Stock-Based Compensation to Revenue
 299.39 299.45 10.47 0.00 0.00
Income Quality
 0.92 0.92 -0.21 0.95 0.68